institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Teddi Mellencamp Shares Immunotherapy Is Making Her "Sicker" Amid Cancer Journey

LOS ANGELES COUNTY, CALIFORNIA, JUL 24 – Teddi Mellencamp halted immunotherapy after doctors warned the treatment could worsen her condition despite earlier scans showing tumor shrinkage, with a 50% survival chance given.

  • On the July 23 episode of Two T's in a Pod, Teddi Mellencamp announced she’s pausing immunotherapy after doctors found it was worsening her condition.
  • Before pausing treatment, Mellencamp was diagnosed with stage IV metastatic melanoma in October 2022, which progressed to tumors in her brain and lungs by February, prompting surgery.
  • What's happening with me is the longer that I'm on immunotherapy, the sicker it's making me, Mellencamp said, and after an emergency appointment she learned continuing treatment would worsen her condition.
  • Pausing immunotherapy, she’ll begin steroids to rebuild her strength and `we're doing everything we can to get me back to feeling like I can do this, I can do all the things,` she said.
  • It's stage 4 until it's gone, until I'm in remission,` Mellencamp said, and doctors plan for her to continue immunotherapy for at least two more years.
Insights by Ground AI
Does this summary seem wrong?

15 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 56% of the sources are Center
56% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

US Magazine broke the news in United States on Thursday, July 24, 2025.
Sources are mostly out of (0)